Full text

Turn on search term navigation

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Myofunctional therapy (MT) is used to treat sleep-disordered breathing. However, MT has low adherence—only ~10% in most studies. We describe our experiences with MT delivered through a mobile health app named Airway Gym®, which is used by patients who have rejected continuous positive airway pressure and other therapies. We compared ear, nose, and throat examination findings, Friedman stage, tongue-tie presence, tongue strength measured using the Iowa oral performance instrument (IOPI), and full polysomnography before and after the 3 months of therapy. Participants were taught how to perform the exercises using the app at the start. Telemedicine allowed physicians to record adherence to and accuracy of the exercise performance. Fifty-four patients were enrolled; 35 (64.8%) were adherent and performed exercises for 15 min/day on five days/week. We found significant changes (p < 0.05) in the apnoea–hypopnoea index (AHI; 32.97 ± 1.8 to 21.9 ± 14.5 events/h); IOPI score (44.4 ± 11.08 to 49.66 ± 10.2); and minimum O2 saturation (80.91% ± 6.1% to 85.09% ± 5.3%). IOPI scores correlated significantly with AHI after the therapy (Pearson r = 0.4; p = 0.01). The 19 patients who did not adhere to the protocol showed no changes. MT based on telemedicine had good adherence, and its effect on AHI correlated with IOPI and improvement in tongue-tie.

Details

Title
Improving Adherence to Myofunctional Therapy in the Treatment of Sleep-Disordered Breathing
Author
Carlos O’Connor-Reina 1   VIAFID ORCID Logo  ; Garcia, Jose María Ignacio 2 ; Laura Rodriguez Alcala 1   VIAFID ORCID Logo  ; Elisa Rodríguez Ruiz 2 ; Garcia Iriarte, María Teresa 3 ; Casado Morente, Juan Carlos 4 ; Baptista, Peter 5   VIAFID ORCID Logo  ; Plaza, Guillermo 6 

 Otorhinolaryngology Department, Hospital Quironsalud Marbella, 29603 Marbella, Spain; [email protected] (C.O.-R.); [email protected] (L.R.A.); [email protected] (J.C.C.M.); Otorhinolaryngology Department, Hospital Quironsalud Campo de Gibraltar, 11379 Palmones, Spain 
 Pulmonology Department, Hospital Quironsalud Marbella, 29603 Marbella, Spain; [email protected] (J.M.I.G.); [email protected] (E.R.R.) 
 Otorhinolaryngology Department, Hospital Virgen de Valme, 41014 Sevilla, Spain; [email protected] 
 Otorhinolaryngology Department, Hospital Quironsalud Marbella, 29603 Marbella, Spain; [email protected] (C.O.-R.); [email protected] (L.R.A.); [email protected] (J.C.C.M.) 
 Otorhinolaryngology Department, Clínica Universitaria de Navarra, 31008 Pamplona, Spain; [email protected] 
 Otorhinolaryngology Department, Hospital Universitario de Fuenlabrada, Universidad Rey Juan Carlos, 28942 Madrid, Spain; Otorhinolaryngology Department, Hospital Sanitas la Zarzuela, 28942 Madrid, Spain 
First page
5772
Publication year
2021
Publication date
2021
Publisher
MDPI AG
e-ISSN
20770383
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2612791411
Copyright
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.